Fact Sheets

Проект USAID по Противодействию ВИЧ направлен на сни-жение количества новых случаев ВИЧ-инфекции среди ключевых групп населения в местах лишения свободы и после освобождения в Таджикистане, Кыргызстане и Ка-захстане. Проект будет предоставлять техническую поддержку, обучение, социальное сопровождение в переходный период и профилактические услуги для осужденных и лиц, освободившихся из мест лишения свободы в трех странах, а также улучшит качество наркологических услуг и их взаимосвязь со СПИД Центрами, юридическими и социальными сервисами для целевой группы.

Проект будет работать на всех уровнях здравоохранения: с сообществом и с Правительством Кыргызской Республики. Для повышения эффективности системы выявления ТБ и улучшения результатов лечения проект будет оказывать всестороннюю поддержку Национальной Противотуберкулезной Программе и работать по внедрению стратегии здравоохранения по ТБ «Ден Соолук-2020». Проект будет способствовать полному переходу к амбулаторному лечению туберкулеза.

The Project will work on all levels of the health care sector with community and government, to improve TB case-finding and treatment results, through overall support to the National Tuberculosis Program in implementing the Den Sooluk-2020 Health Care Strategy on TB. The Project will support an overall shift to patient-centered care for tuberculosis.

USAID’s HIV React project works reduce HIV transmission in Tajikistan, the Kyrgyz Republic, and Kazakhstan among key populations in detention and post-detention settings. The project provides technical assistance, training, transitional client management and prevention services to reduce HIV transmission among prisoners and post release inmates in these three countries and strengthen the quality of narcology services and their linkages with AIDS centers and legal and social support services for prisoners and ex-prisoners.

Duration:  August 2014 – June 2018

Implementing Partner:  Deloitte Consulting, Inc.

Key Partners:  Kyrgyz apparel, tour-ism and construction materials firms, business associations, consulting firms and NGOs, Government Minis-tries and Agencies

Activity Locations:  Nationwide

Activity Goal

The U.N. World Health Organization (WHO) announced the official end to the EVD outbreaks in Nigeria and Senegal on October 17 and 20, respectively, after both countries completed two 21-day cycles without an additional reported case.  CDC supported the governments of Nigeria and Senegal with epidemiological surveillance as part of the countries’ successful response efforts.

The Development Innovation Accelerator (DIA or the Accelerator) is a tool specifically focused on Science, Technology, Innovation and Partnership (STIP), managed by the Global Development Lab.

Care and safety of personnel responding to the Ebola epidemic is of paramount concern. From personal protective equipment (PPE) to medical treatment and medical evacuation (MEDEVAC) we are exploring every avenue to ensure the care and safety of responders. All G-7 countries, including the United States, publicly acknowledged this in a joint statement issued 25 September.

Women’s empowerment is inextricably linked to security, economic opportunity, effective governance, and social development. Investments in women are the single most effective poverty alleviation mechanism contributing to a society’s prosperity. Over the past decade, USAID has helped Afghan women and girls achieve dramatic progress. Promote is an example of the U.S. Government’s continued commitment to Afghan women to ensure these gains are solidified during the transition and through the transformational decade.

USAID Administrator Rajiv Shah is traveling to Liberia, Sierra Leone, Guinea, and Senegal from October 13–17 to meet with national and local officials, aid organizations, and staff coordinating the international response to the Ebola outbreak in West Africa. USAID is helping coordinate the USG’s whole-of-government response to the EVD outbreak that leverages broad expertise and personnel from several federal departments and agencies, including DoD, Department of Health and Human Services, the Department of State, and CDC. On October 14, in Monrovia, Liberia, Administrator Shah announced nearly $142 million in USAID humanitarian activities to support the EVD response. The USAID activities in Guinea, Liberia, and Sierra Leone include construction and support of EVD treatment units (ETUs), critical training for health care workers (HCWs), and social messaging and mobilization.


Last updated: July 31, 2015